Habil, Jalil H.

HRN: 16-68-20  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/02/2022
CEFTRIAXONE 1G (VIAL)
11/02/2022
11/08/2022
IVT
2gms
Od
UTI; R/o Dengue Fever; R/o Typhoid Fever
Waiting Final Action 
08/06/2023
AMOXICILLIN 500MG CAPSULE (CAP)
08/06/2023
08/20/2023
ORAL
1 Gram
BID
H Pylori Infection
Waiting Final Action 
08/06/2023
CLARITHROMYCIN 500MG (CAP)
08/06/2023
08/20/2023
ORAL
500mg
BID
H Pylori Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: